Liposomes: Advancements and innovation in the manufacturing process

Area of Science:

• Pharmaceutical Sciences
• Biotechnology
• Chemical Engineering

Background:

• Liposomes are established drug delivery systems with approved products.
• Current manufacturing is often complex, multi-batch, and difficult to scale from the lab.
• Challenges in scaling hinder the development and adoption of new liposomal systems.

Purpose of the Study:

• To review and evaluate diverse liposome manufacturing processes from lab to large scale.
• To identify advantages and limitations of existing and emerging liposome production methods.
• To discuss regulatory considerations for liposome manufacture.

Main Methods:

• Comprehensive literature review of liposome manufacturing techniques.
• Evaluation of scalability, efficiency, and limitations of various production methods.
• Analysis of critical process attributes impacting liposome product quality.

Main Results:

• Traditional methods present scale-up difficulties and process complexity.
• Emerging innovations like self-assembling systems and microfluidics offer leaner, scalable solutions.
• Identification of critical process attributes is key for successful innovation adoption.

Conclusions:

• Advancements in manufacturing processes are crucial for liposome innovation.
• Scalable technologies like microfluidics show promise for efficient large-scale liposome production.
• Understanding process-product relationships supports wider adoption of new manufacturing strategies.